Ocrevus

Product manufactured by Genentech, Inc.

Application Nr Approved Date Route Status External Links
BLA761053 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ocrevus Is Indicated For The Treatment Of: Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults Primary Progressive Ms, In Adults Ocrevus Is A Cd20-Directed Cytolytic Antibody Indicated For The Treatment Of: Relapsing Forms Of Multiple Sclerosis (Ms), To Include Clinically Isolated Syndrome, Relapsing-Remitting Disease, And Active Secondary Progressive Disease, In Adults ( 1 ) Primary Progressive Ms, In Adults ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ocrelizumab

Comments